FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy

Published:2015-11-27 Issue:2 Volume:30 Page:114-121
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Kremer Ran,Peysakhovich Yury,Dan Levy-Faber,Guralnik Ludmila,Kagna Olga,Nir Rony-Reuven,Bar-Shalom Rachel

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12149-015-1038-7.pdf

Reference24 articles.

1. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention. J Nat Cancer Ins. 2003;95(17):1276–9.

2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5–26.

3. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594–606.

4. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med. 2004;3550:379–92.

5. Kobrinsky NL, Klug MG, Hokanson PJ, Sjolander DE, Burd L. Impact of smoking on cancer stage and diagnosis. J Clin Oncol. 2003;21:907.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA–B GFPC 04-2020Study);Lung Cancer;2024-08

2. PET/CT in treatment response assessment in lung cancer. When should it be recommended?;Nuclear Medicine Communications;2023-09-14

3. 18F-FDG PET/CT for Response Assessment in Lung Cancer;Seminars in Nuclear Medicine;2022-11

4. Surgical or medical strategy for locally-advanced, stage IIIA/B-N2 non-small cell lung cancer: Reproducibility of decision-making at a multidisciplinary tumor board;Lung Cancer;2022-01

5. Place and Role of PET/CT in the Diagnosis and Staging of Lung Cancer;Medical Radiology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3